
Rigel Pharmaceuticals Continues To Grow While The Stock Remains Subdued – Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
Rigel Pharmaceuticals (RIGL) recently reported their Q4/2019 earnings with a beat on EPS and revenue. The company posted a strong 2019 with respectable commercial numbers and focused effort on executing their 4 key value drivers […]